CITY OF INDUSTRY, Calif., Feb. 8, 2005 (PRIMEZONE) -- U.S. BioDefense (OTCBB:UBDE) is pleased to announce today that it has signed a secrecy agreement with the office of technology transfer at a NYSE listed $4 Billion Biomedical company to further explore the potential of a new product commercialization relationship in line with its Stem Cell technology transfer initiative. There is definitely a strong interest in leveraging a California based stem cell technology transfer initiative by both companies and this is another example of rapid progress being spearheaded on the west coast.
